| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study
|
Nicosia, L.
|
|
|
166 |
C |
p. 92-99
|
artikel
|
| 2 |
An examination of nationwide trends in accelerated partial breast irradiation – The replacement of breast brachytherapy with intraoperative radiotherapy and external beam radiation
|
Ladbury, Colton
|
|
|
166 |
C |
p. 79-87
|
artikel
|
| 3 |
A systematic review and meta-analysis of liver tumor position variability during SBRT using various motion management and IGRT strategies
|
Sharma, Manju
|
|
|
166 |
C |
p. 195-202
|
artikel
|
| 4 |
Comment to “Long term results of a phase II trial of hypofractionated adjuvant radiotherapy for early-stage breast cancer with volumetric modulated arc therapy and simultaneous integrated boost”
|
Kao, Yung-Shuo
|
|
|
166 |
C |
p. 100
|
artikel
|
| 5 |
Contents
|
|
|
|
166 |
C |
p. iii-iv
|
artikel
|
| 6 |
CT-guided versus MR-guided radiotherapy: Impact on gastrointestinal sparing in adrenal stereotactic body radiotherapy
|
Rodriguez, Lori L.
|
|
|
166 |
C |
p. 101-109
|
artikel
|
| 7 |
Development of a web-based prognostic model to quantify the survival benefit of cumulative cisplatin dose during concurrent chemoradiotherapy in childhood nasopharyngeal carcinoma
|
Jin, Ya-Nan
|
|
|
166 |
C |
p. 118-125
|
artikel
|
| 8 |
Does bridging radiation therapy affect the pattern of failure after CAR T-cell therapy in non-Hodgkin lymphoma?
|
Saifi, Omran
|
|
|
166 |
C |
p. 171-179
|
artikel
|
| 9 |
Editorial Board
|
|
|
|
166 |
C |
p. ii
|
artikel
|
| 10 |
First demonstration of the FLASH effect with ultrahigh dose rate high-energy X-rays
|
Gao, Feng
|
|
|
166 |
C |
p. 44-50
|
artikel
|
| 11 |
Gastric deformation models for adaptive radiotherapy: Personalized vs population-based strategy
|
Bleeker, Margot
|
|
|
166 |
C |
p. 126-132
|
artikel
|
| 12 |
Heterogeneous immunogenicity of SARS-CoV-2 vaccines in cancer patients receiving radiotherapy
|
Bowes, Cynthia L.
|
|
|
166 |
C |
p. 88-91
|
artikel
|
| 13 |
Hyperbaric oxygen treatment of mandibular osteoradionecrosis: Combined data from the two randomized clinical trials DAHANCA-21 and NWHHT2009-1
|
Forner, Lone E.
|
|
|
166 |
C |
p. 137-144
|
artikel
|
| 14 |
Local tumor control and treatment related toxicity after plaque brachytherapy for uveal melanoma: A systematic review and a data pooled analysis
|
Buonanno, Francesca
|
|
|
166 |
C |
p. 15-25
|
artikel
|
| 15 |
Master protocol trial design for technical feasibility of MR-guided radiotherapy
|
Couwenberg, Alice
|
|
|
166 |
C |
p. 33-36
|
artikel
|
| 16 |
Patterns and predictors of relapse in Merkel cell carcinoma: Results from a population-based study
|
Joseph, Kurian
|
|
|
166 |
C |
p. 110-117
|
artikel
|
| 17 |
Performance of an integrated multimodality image guidance and dose-planning system supporting tumor-targeted HDR brachytherapy for prostate cancer
|
Grajales, David
|
|
|
166 |
C |
p. 154-161
|
artikel
|
| 18 |
Personalised radiation therapy taking both the tumour and patient into consideration
|
Overgaard, Jens
|
|
|
166 |
C |
p. A1-A5
|
artikel
|
| 19 |
Photon beam modeling variations predict errors in IMRT dosimetry audits
|
Glenn, Mallory C.
|
|
|
166 |
C |
p. 8-14
|
artikel
|
| 20 |
Postoperative radiotherapy in stage I–III Merkel cell carcinoma
|
Levy, Sonja
|
|
|
166 |
C |
p. 203-211
|
artikel
|
| 21 |
Quality of life, HPV-status and phase angle predict survival in head and neck cancer patients under (chemo)radiotherapy undergoing nutritional intervention: Results from the prospective randomized HEADNUT-trial
|
Kutz, Laura Magdalena
|
|
|
166 |
C |
p. 145-153
|
artikel
|
| 22 |
Radiomics outperforms semantic features for prediction of response to stereotactic radiosurgery in brain metastases
|
Gutsche, Robin
|
|
|
166 |
C |
p. 37-43
|
artikel
|
| 23 |
Radiosensitisation of SCCVII tumours and normal tissues in mice by the DNA-dependent protein kinase inhibitor AZD7648
|
Hong, Cho R.
|
|
|
166 |
C |
p. 162-170
|
artikel
|
| 24 |
Reduction of clinical safety margins in proton therapy enabled by the clinical implementation of dual-energy CT for direct stopping-power prediction
|
Peters, Nils
|
|
|
166 |
C |
p. 71-78
|
artikel
|
| 25 |
Refining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: The Phoenix definition and beyond
|
Ma, Ting Martin
|
|
|
166 |
C |
p. 1-7
|
artikel
|
| 26 |
Results from a prospective, randomised study on (accelerated) preoperative versus (conventional) postoperative radiotherapy in treatment of patients with resectable squamous cell carcinoma of the oral cavity – The ARTSCAN 2 study
|
Wennerberg, Johan
|
|
|
166 |
C |
p. 26-32
|
artikel
|
| 27 |
Single-institution clinical experience using robust intensity modulated proton therapy in chordoma and chondrosarcoma of the mobile spine and sacrum: Feasibility and need for plan adaptation
|
Kroesen, Michiel
|
|
|
166 |
C |
p. 58-64
|
artikel
|
| 28 |
Single-isocenter versus multiple-isocenters for multiple lung metastases: Evaluation of lung dose
|
van Timmeren, Janita E.
|
|
|
166 |
C |
p. 189-194
|
artikel
|
| 29 |
Temporal changes and risk factors for esophageal stenosis after salvage radiotherapy in superficial esophageal cancer following non-curative endoscopic submucosal dissection
|
Nishibuchi, Ikuno
|
|
|
166 |
C |
p. 65-70
|
artikel
|
| 30 |
The clinical efficacy of low-dose whole-lung irradiation in moderate-to-severe COVID-19 pneumonia: RTMX-20 trial
|
Ortiz, Cindy S.
|
|
|
166 |
C |
p. 133-136
|
artikel
|
| 31 |
The radiotherapy quality assurance gap among phase III cancer clinical trials
|
Corrigan, Kelsey L.
|
|
|
166 |
C |
p. 51-57
|
artikel
|
| 32 |
Variable and fixed costs in NHS radiotherapy; consequences for increasing hypo fractionation
|
Spencer, Katie
|
|
|
166 |
C |
p. 180-188
|
artikel
|
Tijdschrift beschrijving